Nausea, bloating and indigestion often settle once the body adapts to the dose
OSA obstructive sleep apnoea, AHI apnoea-hypopnea index, CPAP continuous positive airway pressure, SGLT2 sodium-glucose co-transporters 2, EMPA empagliflozin, DAPA dapagliflozin, ERTU ertugliflozin, LUSEO luseogliflozin, GLIME glimepiride, MET metformin, SDB sleep disordered breathing, ODI oxygen desaturation index, BW body weight, RR relative risk, LSpO 2 minimum oxygen saturation, ESS Epworth Somnolence Scale, HOMA-IR Homeostatic Model Assessment for Insulin Resistance, MED medication, Ref
Any of these rare symptoms should prompt cessation of the GLP-1 injection, check of the blood sugar (finger monitor), and doctor visit
Weight trajectories after last tirzepatide or semaglutide prescription across a federated health network